1-9 of 9
Irene S. DeGutis
Close
Sort by
Journal Articles

Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

David L. Grinblatt, Gail J. Roboz, Daniel A. Pollyea, Mikkael A. Sekeres, Bart L. Scott, Karen Seiter, Amer M. Zeidan, Jay L. Patel, Guillermo Garcia-Manero, Rami S. Komrokji, Michael R. Savona, Irene S. Degutis, Pavel Kiselev, Edward Yu, Willem Heydendael, Ying Qiu, Sara Vergara, Ali McBride, Harry P. Erba
Journal: Blood
Blood (2023) 142 (Supplement 1): 593.
https://doi.org/10.1182/blood-2023-189963
Published: 2023
Journal Articles

Five-Year Overall Survival Analysis Using First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase in a Prospective Observational Study (SIMPLICITY)

Michael Mauro, Ronald Paquette, Rüdiger Hehlmann, Loretta A. Williams, Stuart L. Goldberg, Mauricette Michallet, Carlo Gambacorti-Passerini, Derek Tang, Irene S. DeGutis, Ali McBride, Lori Parsons, Monica Z. Montelongo, Jorge E. Cortes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9624–9625.
https://doi.org/10.1182/blood-2022-163080
Published: 2022
Journal Articles

Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes

Mikkael A. Sekeres, Guillermo Garcia-Manero, David L. Grinblatt, Rami S. Komrokji, Michael R. Savona, Harry P. Erba, Gail J. Roboz, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Adeola Y. Makinde, Ali McBride, Bart L. Scott
Journal: Blood
Blood (2022) 140 (Supplement 1): 9818–9820.
https://doi.org/10.1182/blood-2022-158075
Published: 2022
Journal Articles

Long-Term Molecular Testing and Clinical Response of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase: 5-Year Follow-up from SIMPLICITY, a Prospective, Observational Study

Jorge E. Cortes, Stuart L. Goldberg, Ronald Paquette, Loretta A. Williams, Rüdiger Hehlmann, Mauricette Michallet, Carlo Gambacorti-Passerini, Derek Tang, Irene S. DeGutis, Ali McBride, Lori Parsons, Monica Z. Montelongo, Michael Mauro
Journal: Blood
Blood (2022) 140 (Supplement 1): 3902–3903.
https://doi.org/10.1182/blood-2022-163063
Published: 2022
Journal Articles

Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT® Myeloid Registry Study

Bart L. Scott, Michael R. Savona, Gail J. Roboz, Karen Seiter, Daniel A. Pollyea, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood
Blood (2022) 140 (Supplement 1): 8923–8925.
https://doi.org/10.1182/blood-2022-158068
Published: 2022
Journal Articles

Treatment Patterns and Outcomes of Patients with NPM1 + Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry

Daniel A. Pollyea, Jaroslaw P. Maciejewski, Gail J. Roboz, Karen Seiter, Bart L. Scott, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood
Blood (2022) 140 (Supplement 1): 11844–11846.
https://doi.org/10.1182/blood-2022-156679
Published: 2022
Journal Articles

The Use of Fedratinib for Myelofibrosis As a Potential Bridge to Hematopoietic Stem Cell Transplantation after Ruxolitinib Failure: Real-World Assessment of Treatment Characteristics and Spleen, Symptom, and Hematologic Response

John Mascarenhas, Claire Harrison, Tammy Schuler, Djibril Liassou, Marné Garretson, Sankar Mahadevan, Ali McBride, Derek Tang, Irene S. DeGutis, Pranav Abraham, Aaron T. Gerds
Journal: Blood
Blood (2022) 140 (Supplement 1): 5276–5278.
https://doi.org/10.1182/blood-2022-156780
Published: 2022
Journal Articles

Treatment Patterns and Survival Outcomes of Patients with Acute Myeloid Leukemia Who Achieved Remission in the Connect ® Myeloid Disease Registry

Gail J. Roboz, Mehrdad Abedi, Michael A. Thompson, Mikkael A. Sekeres, Daniel A. Pollyea, Karen Seiter, Edward Yu, Pavel Kiselev, Michelle Little, Irina Fernandez, Irene S. DeGutis, Harry P. Erba
Journal: Blood
Blood (2021) 138 (Supplement 1): 279.
https://doi.org/10.1182/blood-2021-145849
Published: 2021
Journal Articles

Treatment Patterns and Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes in the Connect ® Myeloid Disease Registry

Rami S. Komrokji, Tracy I. George, Harry P. Erba, Bart L. Scott, David L. Grinblatt, Jaroslaw P. Maciejewski, Gail J. Roboz, Michael R. Savona, Guillermo Garcia-Manero, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Adeola Y. Makinde, Mikkael A. Sekeres
Journal: Blood
Blood (2021) 138 (Supplement 1): 3686.
https://doi.org/10.1182/blood-2021-145853
Published: 2021